Boston Scientific Corp (BSX)

Gross profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Gross profit (ttm) US$ in thousands 11,224,000 10,707,000 10,225,000 10,169,000 9,871,000 9,511,000 9,276,000 8,969,000 8,679,000 8,606,000 8,444,000 8,342,000 8,129,000 7,678,000 7,438,000 6,522,000 6,401,000 6,744,000 6,881,000 7,533,000
Revenue (ttm) US$ in thousands 16,746,000 15,910,000 15,228,000 14,707,000 14,240,000 13,757,000 13,400,000 13,045,000 12,682,000 12,567,000 12,329,000 12,162,000 11,888,000 11,469,000 11,196,000 10,122,000 9,913,000 10,110,000 10,158,000 10,786,000
Gross profit margin 67.02% 67.30% 67.15% 69.14% 69.32% 69.14% 69.22% 68.75% 68.44% 68.48% 68.49% 68.59% 68.38% 66.95% 66.43% 64.43% 64.57% 66.71% 67.74% 69.84%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $11,224,000K ÷ $16,746,000K
= 67.02%

The gross profit margin of Boston Scientific Corp has shown some fluctuations over the past few years. It was relatively high at around 69% in the first half of 2020 but then decreased to around 64-66% by the end of the year. However, there was a positive trend in the following years, with the gross profit margin gradually increasing to around 69% by the beginning of 2024.

Overall, the company has seen improvement in its gross profit margin over the years, indicating efficient cost management and potentially higher pricing power. It is essential to continue monitoring this ratio to ensure sustained profitability and competitiveness in the market.


See also:

Boston Scientific Corp Gross Profit Margin (Quarterly Data)